Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$814.01K-$814.01KderivedN/M vs Q4 2022 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$655,109N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
Operating Cash Flowderived-$119,846N/M ended Jul 31, 2023 · filed Oct 30, 2023 · 91 d after period end